Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy

Journal of Laboratory and Clinical Medicine

Volumn 143, Issue 5, 2004, Pages 284-291

  Zhao, Robert Chunhua ^a   Liao, Lianming ^b   Han, Qin ^b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ALLOGRAFT; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CELL STIMULATION; CELL SURVIVAL; CYTOKINE RELEASE; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MESENCHYME CELL; NONHUMAN; PATIENT; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

EID: 2342639578     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2003.11.009     Document Type: Review

References (53)

1. Wekerle T, Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 2001;52:353-70.
2. Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991;114:954-5.
3. Helg C, Chapuis B, Bolle JF, Morel P, Salomon D, Roux E, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 1994;58:1420-2.
4. Sorof JM, Koerper MA, Portale AA, Potter D, DeSantes K, Cowan M. Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation. Transplantation 1995;59:1633-5.
5. Fandrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002;8:171-8.
6. Han Q, Deng W, Li C, Liao L, Ge W, Zhao Z, et al. Allogeneic adult stem cells establish long-term residence in recipient tissues and facilitate skin transplantation [abstract]. Exp Hematol 2003;31:158.
7. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8.
8. Frassoni FLM, Bacigalupo A, Gluckman E. Expanded mesenchymal stem cells (MSC), coinfused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis [abstract]. Bone Marrow Transplant 2002;29:75.
9. Lazarus H, Curtin P, Devine S. Role of mesenchymal stem cells in allogeneic transplantation: early phase 1 clincial results [abstract]. Blood 2000;96:392.
10. Fridenstein A. Stromal bone marrow cells and the hematopoietic microenvironment. Arkh Patol 1982;44:3-11.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
12. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875-84.
13. Deans RJ. Mesenchymal stem cells: cell and gene therapy applications. Eur Cytokine Networks 2000;11:323-4.
14. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001;68:245-53.
15. Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X, et al. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med 2003;141:342-9.
16. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62.
17. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28.
18. + cells in NOD/SCID mice. Exp Hematol 2002;30:870-8.
19. Hu Y, Zhang LY, Ma GJ, Jiang XY, Zhao CH. Phenotypical and biological characteristics of human fetal marrow and liver mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2001;9:289-93.
20. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-42.
21. Simons PG, Torok-Storb B. Identification pf stromal cell precursors in human bone marrow by a novel monoclonal antibody STRO-1. Blood 1991;78:55-62.
22. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998;338:1813-21.
23. von Boehmer H, Kisielow P. Self-nonself discrimination by T cells. Science 1990;248:1369-73.
24. Anderson G, Jenkinson EJ, Moore NC, Owen JJT. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 1993;362:70-73.
25. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998;280:243-48.
26. Charlton B, Auchincloss H Jr, Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol 1994;12:707-34.
27. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994;6:757-64.
28. Li XC, Strom TB, Turka LA, Wells AD. T cell death and transplantation tolerance. Immunity 2001;14:407-16.
29. Sykes M, Sachs DH. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 1988;9:23-7.
30. Di Nicola M, Carlo-Stella C, Magni M, Marco Milanesi, Longoni PD, Matteucci P. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-43.
31. Chen JL, Guo ZK, Xu C, Li YH, Hou CM, Mao N, et al. Mesenchymal stem cells suppress allogeneic T cell responses by secretion of TGF-beta1. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2002;10:285-8.
32. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-97.
33. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20.
34. He J, Zhang Y, Jiang XX, Liu G, Liu YL, Li HL, et al. Effect of human bone marrow mesenchymal stem cell on cord blood T lymphocyte transformation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003;11:11-4.
35. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-9.
36. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, et al. Long-term distribution of adult stem cells in different tissues after transplantation. Stem Cell Cell Ther 2003;1:62-5.
37. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001.
38. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats: similarities to astrocyte grafts. Proc Natl Acad Sci U S A 1998;95:3908-14.
39. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
40. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002;74:19-24.
41. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-6.
42. Silverstein AM, Prendergast RA, Kraner KL. Fetal response to antigenic stimulus. IV. Rejection of skin homografts by the fetal lamb. J Exp Med 1964;119:955-64.
43. Zanjani E, Almeida-Porada G, Ascensao J, Mackintosh F, Flake A. Transplantation of hematopoietic stem cells in utero. Stem Cell 1997;15:79-93.
44. Li Y, Hisha H, Inaba M, Lian Z, Yu C, Kawamura M, et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp Hematol 2000;28:950-60.
45. BardaSaad M, Rozenszajn LA, Ashush H, Shav-Tal Y, Nun AB, Zipori D. Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells. Exp Hematol 1999;27:834-44.
46. Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, et al. Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell cycle progression. J Immunol 1990;144:1769-76.
47. Ahuja SS, Paliogianni F, Yarnada H, Balow JE, Boumpas DT. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol 1993;150:3109.
48. Fox FE, Ford HC, Douglas R, Cherian S, Nowell PC. Evidence that TGF-β can inhibit T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell Immunol 1993;150:45-58.
49. Mossalayi MD, Mentz F, Ouaaz F, Dalloul AH, Blanc C, Debre P, et al. Early human thymocyte proliferation is regulated by an externally controlled autocrine transforming growth factor-β1 mechanism. Blood 1995;85:3594-601.
50. Barda-Saad M, Rozenszajn LA, Globerson A, Zhang AS, Zipori D. Selective adhesion of immature thymocytes to bone marrow-stromal cells: relevance to T cell lymphopoiesis. Exp Hematol 1996;4:386.
51. + thymocyte maturation: pre-T and NK cell differentiation on neonatal thymic stromal cell culture. Cell Immunol 1998;190:23.
52. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994;152:3119-27.
53. Lee ST, Jang JH, Cheong JW, Kim JS, Maemg HY, Hahn JS, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 2002;118:1128-31.